Clinical trial
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Incobotulinumtoxin Type A for the Functional Improvement of Lower Extremity Spasticity in Patients With Multiple Sclerosis
NCT01968902 is registered in ClinicalTrials.gov with Multiple Sclerosis Center of Northeastern New York as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Incobotulinumtoxin Type A for the Functional Improvement of Lower Extremity Spasticity in Patients With Multiple Sclerosis
- Lead sponsor
- Multiple Sclerosis Center of Northeastern New York
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2013
- Completion date
- December 31, 2016
- Enrollment
- 27 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.